Pre-view research, som citeret af den amerikanske sundhedsmyndighed CDC, viser, at Omicron i forhold til Delta udløser 74 % færre COVID-ramte i respirator og 91 procent færre døde. Der er altså grund til at forvente, alene af den grund, færre danskere i respirator og døde, når de sidste Delta-syge kommer ud af systemet, enten som raske eller døde.
De danske sundhedsmyndigheder oplyser af en eller anden besynderlig årsag ikke, hvor mange af de aktuelle danskere i respirator, der har Delta eller Omicron, ejheller om fordelingen af de nye døde på henholdsvis Delta og Omicorn. Men med den meget lave dødelighed af Omicron, de færre danskere i respirator, trods 25.000-30.000 nye daglige smittede, er der grund til at tro, at antallet af danskere i respirator og intensiv indlæggelser fortsat vil falde. Anden forskning viser , at den gennemsnitloige indlæggelsestid med Omicron er faldet over 60 %, til ca.3-4 dage. Det stemmer overens med danske data.
Læs her pre view forskningen fra Medrxiv:
Results Our analyses included 52,297 cases with SGTF (Omicron) and 16,982 cases with non-SGTF (Delta [B.1.617.2]) infections, respectively. Hospital admissions occurred among 235 (0.5%) and 222 (1.3%) of cases with Omicron and Delta variant infections, respectively. Among cases first tested in outpatient settings, the adjusted hazard ratios for any subsequent hospital admission and symptomatic hospital admission associated with Omicron variant infection were 0.48 (0.36-0.64) and 0.47 (0.35-0.62), respectively.
Rates of ICU admission and mortality after an outpatient positive test were 0.26 (0.10-0.73) and 0.09 (0.01-0.75) fold as high among cases with Omicron variant infection as compared to cases with Delta variant infection. Zero cases with Omicron variant infection received mechanical ventilation, as compared to 11 cases with Delta variant infections throughout the period of follow-up (two-sided p<0.001). Median duration of hospital stay was 3.4 (2.8-4.1) days shorter for hospitalized cases with Omicron variant infections as compared to hospitalized patients with Delta variant infections, reflecting a 69.6% (64.0-74.5%) reduction in hospital length of stay.
